Clinical Trial

Weight Loss Following an Episode of Pre-eclampsia Using a Dissociated or Hypocaloric Diet in Overweight or Obese Patients

Study acronym: POPADIPE
Recruiting
View on ClinicalTrials.gov →
Summary
In view of the known link between pre-eclampsia, overweight/obesity and chronic kidney disease, the aim is to offer for obese and overweight patients to reduce their BMI without reducing lean body mass. The POPADIPE project will make it possible to limit overweight or obesity by means of nutritional management chosen by the patient (hypocaloric or a dissociated diet). The latter has been the subject of little scientific investigation, particularly in relation to the management of post-pre-eclampsia.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-09-28.
Trial Details
NCT Number NCT06067906
Lead Sponsor Centre Hospitalier le Mans
Conditions Pre-Eclampsia, Obesity
Enrollment 60 participants
Start Date 2023-11-02
Primary Completion 2028-11-02 (estimated)
Study Completion 2028-11-02 (estimated)
Updated on ClinicalTrials.gov 2024-08-28